| Name | Title | Contact Details |
|---|
Landos pursues safer, more effective first-in-class oral therapeutics for autoimmune disorders at an accelerated rate.
Visus Therapeutics is a clinical-stage company in pursuit of developing the world`s first presbyopia-correcting eye drop with the potential to last at least eight hours. With offices in Seattle, Washington, and Orange County, California, our lead clinical candidate is VTI-001 (BRIMOCHOL™), a once-daily eye drop designed to correct the loss of near vision associated with presbyopia. In parallel, Visus Therapeutics is focused on advancing its pipeline of early-stage ophthalmic product candidates.
EUSA Pharma is a specialty pharma company with a strong and growing portfolio of specialty hospital medicines. It has been built through the acquisition of Talisker Pharmaceuticals in July 2006 and OPi in March 2007. Our primary marketed products are
Harold Crossley is a Cockeysville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Using data to connect patients to therapies that better benefit them.